User contributions for Ztapenguin
Jump to navigation
Jump to search
26 June 2014
- 13:5013:50, 26 June 2014 diff hist +3 User:Ztapenguin No edit summary current
- 13:5013:50, 26 June 2014 diff hist +95 N User:Ztapenguin Created page with "Michele Simmons, Pharm.D. PGY1 Pharmacy Practice Resident The Nebraska Medical Center Omaha, NE"
23 June 2014
- 17:1117:11, 23 June 2014 diff hist +282 Insulin glargine once-daily versus insulin detemir twice-daily in patients with type 2 diabetes inadequately controlled on oral glucose-lowering drugs →Further Reading
- 17:0917:09, 23 June 2014 diff hist +176 Insulin glargine once-daily versus insulin detemir twice-daily in patients with type 2 diabetes inadequately controlled on oral glucose-lowering drugs →Criticisms
- 17:0817:08, 23 June 2014 diff hist +48 Insulin glargine once-daily versus insulin detemir twice-daily in patients with type 2 diabetes inadequately controlled on oral glucose-lowering drugs →Funding
- 17:0717:07, 23 June 2014 diff hist +268 Insulin glargine once-daily versus insulin detemir twice-daily in patients with type 2 diabetes inadequately controlled on oral glucose-lowering drugs →Criticisms
- 17:0417:04, 23 June 2014 diff hist −151 Insulin glargine once-daily versus insulin detemir twice-daily in patients with type 2 diabetes inadequately controlled on oral glucose-lowering drugs →Adverse Events
- 17:0417:04, 23 June 2014 diff hist −102 Insulin glargine once-daily versus insulin detemir twice-daily in patients with type 2 diabetes inadequately controlled on oral glucose-lowering drugs →Subgroup Analysis
- 17:0317:03, 23 June 2014 diff hist +226 Insulin glargine once-daily versus insulin detemir twice-daily in patients with type 2 diabetes inadequately controlled on oral glucose-lowering drugs →Baseline Characteristics
- 17:0117:01, 23 June 2014 diff hist 0 Insulin glargine once-daily versus insulin detemir twice-daily in patients with type 2 diabetes inadequately controlled on oral glucose-lowering drugs →Secondary Outcomes
- 17:0117:01, 23 June 2014 diff hist +570 Insulin glargine once-daily versus insulin detemir twice-daily in patients with type 2 diabetes inadequately controlled on oral glucose-lowering drugs →Outcomes
- 16:4716:47, 23 June 2014 diff hist −359 Insulin glargine once-daily versus insulin detemir twice-daily in patients with type 2 diabetes inadequately controlled on oral glucose-lowering drugs →Interventions
- 16:4416:44, 23 June 2014 diff hist +22 Insulin glargine once-daily versus insulin detemir twice-daily in patients with type 2 diabetes inadequately controlled on oral glucose-lowering drugs →Baseline Characteristics
- 16:4316:43, 23 June 2014 diff hist −362 Insulin glargine once-daily versus insulin detemir twice-daily in patients with type 2 diabetes inadequately controlled on oral glucose-lowering drugs →Population
- 16:1416:14, 23 June 2014 diff hist +35 Insulin glargine once-daily versus insulin detemir twice-daily in patients with type 2 diabetes inadequately controlled on oral glucose-lowering drugs →Design
20 June 2014
- 21:4421:44, 20 June 2014 diff hist +4,496 N Insulin glargine once-daily versus insulin detemir twice-daily in patients with type 2 diabetes inadequately controlled on oral glucose-lowering drugs Created page with "==Clinical Question== Is insulin glargine noninferior to insulin detemir regarding the percentage of patients reaching A1c <7% without symptomatic hypoglycemia with plasma glu..."
19 June 2014
- 21:1621:16, 19 June 2014 diff hist +344 Ondansetron in Pregnancy and Risk of Adverse Fetal Outcomes →Further Reading
- 21:1321:13, 19 June 2014 diff hist +24 Ondansetron in Pregnancy and Risk of Adverse Fetal Outcomes →Funding
- 21:1221:12, 19 June 2014 diff hist +415 Ondansetron in Pregnancy and Risk of Adverse Fetal Outcomes →Criticisms
- 21:0721:07, 19 June 2014 diff hist +1,053 Ondansetron in Pregnancy and Risk of Adverse Fetal Outcomes →Outcomes
- 20:5320:53, 19 June 2014 diff hist +174 Ondansetron in Pregnancy and Risk of Adverse Fetal Outcomes →Interventions
- 20:4720:47, 19 June 2014 diff hist −52 Ondansetron in Pregnancy and Risk of Adverse Fetal Outcomes →Population
- 20:4020:40, 19 June 2014 diff hist −917 Ondansetron in Pregnancy and Risk of Adverse Fetal Outcomes →Design
- 20:3820:38, 19 June 2014 diff hist −263 Ondansetron in Pregnancy and Risk of Adverse Fetal Outcomes →Outcomes
- 20:3720:37, 19 June 2014 diff hist −483 Ondansetron in Pregnancy and Risk of Adverse Fetal Outcomes →Design
- 20:3620:36, 19 June 2014 diff hist +50 Ondansetron in Pregnancy and Risk of Adverse Fetal Outcomes →Major Points
13 June 2014
- 20:3020:30, 13 June 2014 diff hist +6,223 N Ondansetron in Pregnancy and Risk of Adverse Fetal Outcomes Created page with "==Clinical Question== Is ondansetron use during pregnancy associated with increased risk of adverse fetal outcomes including spontanteous abortion, stillbirth, any major birth..."